Discover open access scientific publications

Search, annotate, share and cite publications

Publications by KAICHIRO YAMAMOTO

Phase II Study of Neoadjuvant Chemotherapy With Irinotecan Hydrochloride and Nedaplatin Followed by Radical Hysterectomy for Bulky Stage Ib2 to IIb, Cervical Squamous Cell Carcinoma: Japanese Gynecologic Oncology Group Study (JGOG 1065)

Oncology Reports

English

Related publications

Comparison of Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Neoadjuvant Chemoradiation Followed by Radical Hysterectomy With Concurrent Chemoradiation in Locally Advanced Carcinoma Cervix (FIGO Stages IB2, IIA2, IIB): Interim Results of a Randomized Control Study

English

Adjuvant Chemotherapy After Surgery Can Improve Clinical Outcomes for Patients With IB2-IIB Cervical Cancer With Neoadjuvant Chemotherapy Followed by Radical Surgery

Scientific Reports

Multidisciplinary

2018

English

Survival Nomograms After Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer

Cancer Research and Treatment

Cancer Research

Oncology

2018

English

Prognostic Factors for Response to Cisplatin-Based Chemotherapy in Advanced Cervical Carcinoma: A Gynecologic Oncology Group Study

English

Outcomes of Non-High Grade Serous Carcinoma After Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: A Korean Gynecologic Oncology Group Study (OV 1708)

English

Radiation Therapy With or Without Weekly Cisplatin for Bulky Stage 1B Cervical Carcinoma: Follow-Up of a Gynecologic Oncology Group Trial

American Journal of Obstetrics and Gynecology

Gynecology

Obstetrics

2007

English

A Phase I/Ii Study of Extended Field Radiation Therapy With Concomitant Paclitaxel and Cisplatin Chemotherapy in Patients With Cervical Carcinoma Metastatic to the Para-Aortic Lymph Nodes: A Gynecologic Oncology Group Study

English

A Phase II Multicenter Trial of Concurrent Chemoradiotherapy With Weekly Nedaplatin in Advanced Uterine Cervical Carcinoma: Tohoku Gynecologic Cancer Unit Study

English

Combination Chemotherapy With Irinotecan and Cisplatin for Large-Cell Neuroendocrine Carcinoma of the Lung: A Multicenter Phase II Study

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by KAICHIRO YAMAMOTO

Phase II Study of Neoadjuvant Chemotherapy With Irinotecan Hydrochloride and Nedaplatin Followed by Radical Hysterectomy for Bulky Stage Ib2 to IIb, Cervical Squamous Cell Carcinoma: Japanese Gynecologic Oncology Group Study (JGOG 1065)

Related publications

Comparison of Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Neoadjuvant Chemoradiation Followed by Radical Hysterectomy With Concurrent Chemoradiation in Locally Advanced Carcinoma Cervix (FIGO Stages IB2, IIA2, IIB): Interim Results of a Randomized Control Study

Adjuvant Chemotherapy After Surgery Can Improve Clinical Outcomes for Patients With IB2-IIB Cervical Cancer With Neoadjuvant Chemotherapy Followed by Radical Surgery

Survival Nomograms After Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer

Prognostic Factors for Response to Cisplatin-Based Chemotherapy in Advanced Cervical Carcinoma: A Gynecologic Oncology Group Study

Outcomes of Non-High Grade Serous Carcinoma After Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: A Korean Gynecologic Oncology Group Study (OV 1708)

Radiation Therapy With or Without Weekly Cisplatin for Bulky Stage 1B Cervical Carcinoma: Follow-Up of a Gynecologic Oncology Group Trial

A Phase I/Ii Study of Extended Field Radiation Therapy With Concomitant Paclitaxel and Cisplatin Chemotherapy in Patients With Cervical Carcinoma Metastatic to the Para-Aortic Lymph Nodes: A Gynecologic Oncology Group Study

A Phase II Multicenter Trial of Concurrent Chemoradiotherapy With Weekly Nedaplatin in Advanced Uterine Cervical Carcinoma: Tohoku Gynecologic Cancer Unit Study

Combination Chemotherapy With Irinotecan and Cisplatin for Large-Cell Neuroendocrine Carcinoma of the Lung: A Multicenter Phase II Study